Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 59
Filtrar
1.
Cell Death Differ ; 23(12): 1973-1984, 2016 12.
Artículo en Inglés | MEDLINE | ID: mdl-27447114

RESUMEN

Chromosomal abnormalities are implicated in a substantial number of human developmental syndromes, but for many such disorders little is known about the causative genes. The recently described 1q41q42 microdeletion syndrome is characterized by characteristic dysmorphic features, intellectual disability and brain morphological abnormalities, but the precise genetic basis for these abnormalities remains unknown. Here, our detailed analysis of the genetic abnormalities of 1q41q42 microdeletion cases identified TP53BP2, which encodes apoptosis-stimulating protein of p53 2 (ASPP2), as a candidate gene for brain abnormalities. Consistent with this, Trp53bp2-deficient mice show dilation of lateral ventricles resembling the phenotype of 1q41q42 microdeletion patients. Trp53bp2 deficiency causes 100% neonatal lethality in the C57BL/6 background associated with a high incidence of neural tube defects and a range of developmental abnormalities such as congenital heart defects, coloboma, microphthalmia, urogenital and craniofacial abnormalities. Interestingly, abnormalities show a high degree of overlap with 1q41q42 microdeletion-associated abnormalities. These findings identify TP53BP2 as a strong candidate causative gene for central nervous system (CNS) defects in 1q41q42 microdeletion syndrome, and open new avenues for investigation of the mechanisms underlying CNS abnormalities.


Asunto(s)
Proteínas Reguladoras de la Apoptosis/deficiencia , Deleción Cromosómica , Proteínas Supresoras de Tumor/deficiencia , Animales , Proteínas Reguladoras de la Apoptosis/metabolismo , Encéfalo/anomalías , Encéfalo/patología , Embrión de Mamíferos/anomalías , Embrión de Mamíferos/patología , Femenino , Eliminación de Gen , Ventrículos Cardíacos/anomalías , Ventrículos Cardíacos/patología , Imagen por Resonancia Magnética , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Defectos del Tubo Neural/patología , Fenotipo , Síndrome , Proteínas Supresoras de Tumor/metabolismo
2.
Neurology ; 71(22): 1764-9, 2008 Nov 25.
Artículo en Inglés | MEDLINE | ID: mdl-18843099

RESUMEN

BACKGROUND: Native American myopathy (NAM) is an autosomal recessive congenital myopathy first reported in the Lumbee Indian people. Features of NAM include congenital weakness, cleft palate, ptosis, short stature, and susceptibility to malignant hyperthermia provoked by anesthesia. METHOD: We identified five individuals with NAM from the Lumbee population, and hypothesized that these affected individuals have disease alleles shared identical-by-descent inherited from common ancestry. To identify a NAM disease locus, homozygosity mapping methods were employed on a genomewide 10K single-nucleotide polymorphism (SNP) screen. To confirm regions of homozygosity identified in the SNP screen, microsatellite repeat markers were genotyped within those homozygous segments. RESULTS: The SNP data demonstrated five regions of shared homozygosity in individuals with NAM. The additional genotyping data narrowed the region to one common segment of homozygosity spanning D12S398 to rs3842936 mapping to 12q13.13-14.1. Notably, loss of heterozygosity estimates from the SNP data also detected this same 12q region in the affected individuals. CONCLUSION: This study reports the first gene mapping of Native American myopathy (NAM) using single-nucleotide polymorphism-based homozygosity mapping in only a few affected individuals from simplex families and identified a novel NAM locus. Identifying the genetic basis of NAM may suggest new genetic etiologies for other more common conditions such as congenital myopathy and malignant hyperthermia.


Asunto(s)
Cromosomas Humanos Par 12 , Indígenas Norteamericanos/genética , Miopatías Estructurales Congénitas/genética , Adolescente , Adulto , Consanguinidad , Contractura/genética , Análisis Mutacional de ADN , Cartilla de ADN , Femenino , Predisposición Genética a la Enfermedad , Haplotipos , Homocigoto , Humanos , Pérdida de Heterocigocidad , Masculino , Hipertermia Maligna/genética , Debilidad Muscular/genética , Miopatías Estructurales Congénitas/complicaciones , North Carolina , Polimorfismo de Nucleótido Simple , Adulto Joven
3.
Cytogenet Genome Res ; 113(1-4): 313-7, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16575195

RESUMEN

Beckwith-Wiedemann syndrome (BWS) is an overgrowth syndrome demonstrating heterogeneous molecular alterations of two imprinted domains on chromosome 11p15. The most common molecular alterations include loss of methylation at the proximal imprinting center, IC2, paternal uniparental disomy (UPD) of chromosome 11p15 and hypermethylation at the distal imprinting center, IC1. An increased incidence of female monozygotic twins discordant for BWS has been reported. The molecular basis for eleven such female twin pairs has been demonstrated to be a loss of methylation at IC2, whereas only one male monozygotic twin pair has been reported with this molecular defect. We report here two new pairs of male monozygotic twins. One pair is discordant for BWS; the affected twin exhibits paternal UPD for chromosome 11p15 whereas the unaffected twin does not. The second male twin pair is concordant for BWS and both twins of the pair demonstrate hypermethylation at IC1. Thus, this report expands the known molecular etiologies for BWS twins. Interestingly, these findings demonstrate a new epigenotype-phenotype correlation in BWS twins. That is, while female monozygotic twins with BWS are likely to show loss of imprinting at IC2, male monozygotic twins with BWS reflect the molecular heterogeneity seen in BWS singletons. These data underscore the need for molecular testing in BWS twins, especially in view of the known differences among 11p15 epigenotypes with respect to tumor risk.


Asunto(s)
Síndrome de Beckwith-Wiedemann/genética , Cromosomas Humanos Par 11 , Gemelos Monocigóticos/genética , Mapeo Cromosómico , Inhibidor p57 de las Quinasas Dependientes de la Ciclina , Metilación de ADN , Enfermedades en Gemelos , Femenino , Humanos , Masculino
4.
J Med Genet ; 42(12): 940-6, 2005 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15831595

RESUMEN

Neural tube defects (NTDs) are the second most common birth defects (1 in 1000 live births) in the world. Periconceptional maternal folate supplementation reduces NTD risk by 50-70%; however, studies of folate related and other developmental genes in humans have failed to definitively identify a major causal gene for NTD. The aetiology of NTDs remains unknown and both genetic and environmental factors are implicated. We present findings from a microsatellite based screen of 44 multiplex pedigrees ascertained through the NTD Collaborative Group. For the linkage analysis, we defined our phenotype narrowly by considering individuals with a lumbosacral level myelomeningocele as affected, then we expanded the phenotype to include all types of NTDs. Two point parametric analyses were performed using VITESSE and HOMOG. Multipoint parametric and nonparametric analyses were performed using ALLEGRO. Initial results identified chromosomes 7 and 10, both with maximum parametric multipoint lod scores (Mlod) >2.0. Chromosome 7 produced the highest score in the 24 cM interval between D7S3056 and D7S3051 (parametric Mlod 2.45; nonparametric Mlod 1.89). Further investigation demonstrated that results on chromosome 7 were being primarily driven by a single large pedigree (parametric Mlod 2.40). When this family was removed from analysis, chromosome 10 was the most interesting region, with a peak Mlod of 2.25 at D10S1731. Based on mouse human synteny, two candidate genes (Meox2, Twist1) were identified on chromosome 7. A review of public databases revealed three biologically plausible candidates (FGFR2, GFRA1, Pax2) on chromosome 10. The results from this screen provide valuable positional data for prioritisation of candidate gene assessment in future studies of NTDs.


Asunto(s)
Cromosomas Humanos Par 10 , Cromosomas Humanos Par 7 , Ligamiento Genético , Genoma Humano , Cresta Neural/patología , Defectos del Tubo Neural/genética , Salud de la Familia , Femenino , Marcadores Genéticos , Genotipo , Humanos , Masculino , Modelos Genéticos , Linaje , Mapeo Físico de Cromosoma
6.
Hum Genet ; 109(1): 99-108, 2001 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-11479741

RESUMEN

Hypophosphatasia is an inherited disorder characterized by defective bone mineralization and a deficiency of tissue-nonspecific alkaline phosphatase (TNSALP) activity. The disease is highly variable in its clinical expression, because of various mutations in the TNSALP gene. In approximately 14% of the patients tested in our laboratory, only one TNSALP gene mutation was found, despite exhaustive sequencing of the gene, suggesting that missing mutations are harbored in intron or regulatory sequences or that the disease is dominantly transmitted. The distinction between these two situations is of importance, especially in terms of genetic counseling, but dominance is sometimes difficult to conclusively determine by using familial analysis since expression of the disease may be highly variable, with parents of even severely affected children showing no or extremely mild symptoms of the disease. We report here the study of eight point mutations (G46 V, A99T, S164L, R167 W, R206 W, G232 V, N461I, I473F) found in patients with no other detectable mutation. Three of these mutations, G46 V, S164L, and I473F, have not previously been described. Pedigree and/or serum alkaline phosphatase data suggested possible dominant transmission in families with A99T, R167 W, and G232 V. By means of site-directed mutagenesis, transfections in COS-1 cells, and three-dimensional (3D) modeling, we evaluated the possible dominant effect of these eight mutations. The results showed that four of these mutations (G46 V, A99T, R167 W, and N461I) exhibited a negative dominant effect by inhibiting the enzymatic activity of the heterodimer, whereas the four others did not show such inhibition. Strong inhibition resulted in severe hypophosphatasia, whereas partial inhibition resulted in milder forms of the disease. Analysis of the 3D model of the enzyme showed that mutations exhibiting a dominant effect were clustered in two regions, viz., the active site and an area probably interacting with a region having a particular biological function such as dimerization, tetramerization, or membrane anchoring.


Asunto(s)
Hipofosfatasia/genética , Adolescente , Adulto , Fosfatasa Alcalina/química , Fosfatasa Alcalina/deficiencia , Fosfatasa Alcalina/genética , Dominio Catalítico/genética , Niño , Preescolar , Femenino , Genes Dominantes , Humanos , Hipofosfatasia/enzimología , Lactante , Masculino , Modelos Moleculares , Mutación , Linaje , Fenotipo , Embarazo , Conformación Proteica , Transfección
7.
Am J Med Genet ; 101(4): 345-55, 2001 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-11471158

RESUMEN

Of individuals in the human population, 99.99% have developed identical thoracoabdominal asymmetry with the cardiac apex, a bilobed lung, the stomach, and the spleen on the left side of the midline, and the vena cavae, a trilobed lung, the appendix, and the larger liver lobe on the right. This arrangement of organs is situs solitus. Occasionally, individuals have a complete, mirror-image reversal of this asymmetry called situs inversus, and 20-25% of those individuals have an autosomal recessive condition, Kartagener syndrome, with ciliary dyskinesia, bronchiectasis, sinusitis, and infertility. Between these extremes of situs solitus and situs inversus lies the spectrum of situs ambiguus, characterized by isomerism, heterotaxy, and multiple malformations in one or more thoracic or abdominal organs. Although most abnormal situs in humans occurs sporadically, growing evidence suggests that interference with normal genetic mechanisms and pathways may be responsible for most cases. Familial cases suggest major effects of both autosomal and X-linked genes with both dominant and recessive expression. Situs inversus and situs ambiguus (SI/SA) occurring in probands who have close relatives with "isolated," nonsyndromic birth defects suggests that some of the pathways important in situs determination may also be involved in causing sporadic malformations not obviously associated with a defect in laterality determination. Human phenotypes of interest include the association of SI/SA with short rib-polydactyly syndromes and renal-hepatic-pancreatic dysplasia, and with agnathia and holoprosencephaly. Further elucidation of the developmental pathways involved in left-right axis determination should shed light on the causes of and relationships among these human phenotypes.


Asunto(s)
Tipificación del Cuerpo/genética , Anomalías Congénitas/genética , Animales , Anomalías Congénitas/patología , Modelos Animales de Enfermedad , Lateralidad Funcional , Humanos , Fenotipo
8.
Am J Med Genet ; 101(1): 17-9, 2001 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-11343331

RESUMEN

We describe a patient with type I diabetes, clinical findings consistent with velocardiofacial syndrome, and a chromosome 22q11.2 deletion. A nine-year-old boy presented with a history of polyuria, polydipsia, weight loss, hyperglycemia, ketosis, serum insulin antibodies, and a low C-peptide level. He had distinctive facial features, learning disabilities, short stature, and a history of glottic web and clubfoot. Although a normal karyotype was obtained, fluorescence in situ hybridization (FISH) revealed a submicroscopic deletion in the DiGeorge/velocardiofacial syndrome critical region at 22q11.2. His maternal half-brother also carried a chromosome 22q11.2 deletion. His mother has similar facial features and hypoparathyroidism. Autoimmune problems associated with chromosome 22q11.2 deletions have been reported. We suggest that the defects in immune regulation due to T-cell deficiency in chromosome 22q11.2 deletion syndrome may predispose to autoimmune disorders, including type I diabetes mellitus.


Asunto(s)
Anomalías Múltiples/genética , Deleción Cromosómica , Cromosomas Humanos Par 22 , Anomalías Craneofaciales/genética , Diabetes Mellitus Tipo 1/genética , Niño , Diabetes Mellitus Tipo 1/inmunología , Humanos , Hibridación in Situ , Cariotipificación , Masculino , Fenotipo , Síndrome
9.
Am J Med Genet ; 90(4): 303-9, 2000 Feb 14.
Artículo en Inglés | MEDLINE | ID: mdl-10710228

RESUMEN

Maternal diabetes is known to have teratogenic effects. Malformations including neural tube defects, caudal dysgenesis, vertebral defects, congenital heart defects, femoral hypoplasia, and renal anomalies are described in infants of diabetic mothers. However, craniofacial anomalies have rarely been reported in such infants. Here we document craniofacial anomalies of patients born to diabetic mothers. We describe two patient populations: individuals evaluated through our genetics services for multiple malformations and individuals identified through a database search in our craniofacial clinic. The first group consists of 14 individuals evaluated in our genetics clinics who were born to diabetic mothers and had craniofacial anomalies. The second group consists of seven individuals who were identified from a craniofacial database search of patients with hemifacial microsomia and who were born to diabetic mothers. Thus, both groups were born to diabetic mothers and had hemifacial microsomia (67%), microtia (52%), hearing loss (43%), epibulbar dermoids (24%), and fused cervical vertebrae (24%). Therefore, the teratogenic effects of maternal diabetes probably include such craniofacial malformations as the oculoauriculovertebral/Goldenhar complex. Infants of diabetic mothers should be evaluated for craniofacial anomalies. Conversely, mothers of infants with craniofacial anomalies should be evaluated for diabetes to aid in counseling concerning cause and recurrence risks.


Asunto(s)
Diabetes Mellitus Tipo 1/complicaciones , Diabetes Mellitus Tipo 2/complicaciones , Oído/anomalías , Anomalías del Ojo/complicaciones , Embarazo en Diabéticas/complicaciones , Columna Vertebral/anomalías , Anomalías Múltiples/etiología , Adulto , Femenino , Humanos , Recién Nacido , Masculino , Embarazo
10.
Genomics ; 61(3): 227-36, 1999 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-10552924

RESUMEN

Genome-wide scans have suggested that a locus on 7q is involved in the etiology of autistic disorder (AD). We have identified an AD family in which three sibs inherited from their mother a paracentric inversion in the chromosome 7 candidate region (inv(7)(q22-q31.2)). Clinically, the two male sibs have AD, while the female sib has expressive language disorder. The mother carries the inversion, but does not express AD. Haplotype data on the family suggest that the chromosomal origin of the inversion was from the children's maternal grandfather. Based on these data, we have genotyped 76 multiplex (>/=2 AD affecteds/family) families for markers in this region of 7q. Two-point linkage analysis yielded a maximum heterogeneity lod score of 1.47 and maximum lod score (MLS) of 1.03 at D7S495. Multipoint MLS and NPL analyses resulted in peak scores of 1.77 at D7S2527 and 2.01 at D7S640. Examination of affected sibpairs revealed significant paternal (P = 0.007), but not maternal (P = 0. 75), identity-by-descent sharing at D7S640. Significant linkage disequilibrium was detected with paternal (P = 0.02), but not maternal (P = 0.15), transmissions at D7S1824 in multiplex and singleton families. There was also evidence for an increase in recombination in the region (D7S1817 to D7S1824) in the AD families versus non-AD families (P = 0.03, sex-averaged; and P = 0.01, sex-specific). These results provide further evidence for the presence of an AD locus on chromosome 7q, as well as provide evidence suggesting that this locus may be paternally expressed.


Asunto(s)
Trastorno Autístico/genética , Cromosomas Humanos Par 7/genética , Adulto , Trastorno Autístico/diagnóstico , Preescolar , Inversión Cromosómica , Análisis Citogenético , Femenino , Genotipo , Humanos , Desequilibrio de Ligamiento , Escala de Lod , Masculino , Linaje
11.
Am J Hum Genet ; 65(5): 1268-78, 1999 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-10521292

RESUMEN

Cleidocranial dysplasia (CCD) is a dominantly inherited disorder characterized by patent fontanelles, wide cranial sutures, hypoplasia of clavicles, short stature, supernumerary teeth, and other skeletal anomalies. We recently demonstrated that mutations in the transcription factor CBFA1, on chromosome 6p21, are associated with CCD. We have now analyzed the CBFA1 gene in 42 unrelated patients with CCD. In 18 patients, mutations were detected in the coding region of the CBFA1 gene, including 8 frameshift, 2 nonsense, and 9 missense mutations, as well as 2 novel polymorphisms. A cluster of missense mutations at arginine 225 (R225) identifies this residue as crucial for CBFA1 function. In vitro green fluorescent protein fusion studies show that R225 mutations interfere with nuclear accumulation of CBFA1 protein. There is no phenotypic difference between patients with deletions or frameshifts and those with other intragenic mutations, suggesting that CCD is generally caused by haploinsufficiency. However, we were able to extend the CCD phenotypic spectrum. A missense mutation identified in one family with supernumerary teeth and a radiologically normal skeleton indicates that mutations in CBFA1 can be associated exclusively with a dental phenotype. In addition, one patient with severe CCD and a frameshift mutation in codon 402 had osteoporosis leading to recurrent bone fractures and scoliosis, providing first evidence that CBFA1 may help maintain adult bone, in addition to its function in bone development.


Asunto(s)
Displasia Cleidocraneal/genética , Proteínas de Neoplasias , Factores de Transcripción/genética , Huesos/diagnóstico por imagen , Huesos/patología , Línea Celular , Displasia Cleidocraneal/diagnóstico por imagen , Subunidad alfa 1 del Factor de Unión al Sitio Principal , Factores de Unión al Sitio Principal , Análisis Mutacional de ADN , Mutación del Sistema de Lectura , Proteínas Fluorescentes Verdes , Humanos , Proteínas Luminiscentes , Microscopía Fluorescente , Datos de Secuencia Molecular , Mutación Missense , Fenotipo , Polimorfismo Genético , Radiografía , Proteínas Recombinantes de Fusión , Eliminación de Secuencia , Diente/patología , Transfección
12.
J Med Genet ; 35(6): 456-62, 1998 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-9643285

RESUMEN

The L1 cell adhesion molecule (L1CAM) is a neuronal gene involved in the development of the nervous system. Mutations in L1CAM are known to cause several clinically overlapping X linked mental retardation conditions: X linked hydrocephalus (HSAS), MASA syndrome (mental retardation, aphasia, shuffling gait, adducted thumbs), spastic paraplegia type I (SPG1), and X linked agenesis of the corpus callosum (ACC). In an analysis of a family with HSAS, we identified a C-->T transition (C924T) in exon 8 that was initially thought to have no effect on the protein sequence as the alteration affected the third base of a codon (G308G). Extensive analysis of the other 27 exons showed no other alteration. A review of the sequence surrounding position 924 indicated that the C-->T transition created a potential 5' splice site consensus sequence, which would result in an in frame deletion of 69 bp from exon 8 and 23 amino acids of the L1CAM protein. RT-PCR of the RNA from an affected male fetus and subsequent sequence analysis confirmed the use of the new splice site. This is the first report of a silent nucleotide substitution in L1CAM giving rise to an alteration at the protein level. Furthermore, it shows that as mutation analysis plays an ever more important role in human genetics, the identification of a synonymous base change should not be routinely discounted as a neutral polymorphism.


Asunto(s)
Hidrocefalia/genética , Glicoproteínas de Membrana/genética , Moléculas de Adhesión de Célula Nerviosa/genética , Mutación Puntual , Cromosoma X , Secuencia de Aminoácidos , Antígenos de Superficie/genética , Secuencia de Bases , Niño , Mapeo Cromosómico , Femenino , Tamización de Portadores Genéticos , Humanos , Discapacidad Intelectual/genética , Complejo de Antígeno L1 de Leucocito , Masculino , Glicoproteínas de Membrana/química , Datos de Secuencia Molecular , Moléculas de Adhesión de Célula Nerviosa/química , Linaje , Reacción en Cadena de la Polimerasa , Síndrome
13.
Nat Genet ; 17(3): 305-8, 1997 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-9354794

RESUMEN

Vertebrates position unpaired organs of the chest and abdomen asymmetrically along the left-right (LR) body axis. Each structure comes to lie non-randomly with respect to the midline in an overall position designated situs solitus, exemplified in humans by placement of the heart, stomach and spleen consistently to the left. Aberrant LR axis development can lead to randomization of individual organ position (situs ambiguus) or to mirror-image reversal of all lateralized structures (situs inversus). Previously we mapped a locus for situs abnormalities in humans, HTX1, to Xq26.2 by linkage analysis in a single family (LR1) and by detection of a deletion in an unrelated situs ambiguus male (Family LR2; refs 2,3). From this chromosomal region we have positionally cloned ZIC3, a gene encoding a putative zinc-finger transcription factor. One frameshift, two missense and two nonsense mutations have been identified in familial and sporadic situs ambiguus. The frameshift allele is also associated with situs inversus among some heterozygous females, suggesting that ZIC3 functions in the earliest stages of LR-axis formation. ZIC3, which has not been previously implicated in vertebrate LR-axis development, is the first gene unequivocally associated with human situs abnormalities.


Asunto(s)
Mutación , Situs Inversus/genética , Factores de Transcripción/genética , Cromosoma X , Secuencia de Aminoácidos , Tipificación del Cuerpo/genética , Clonación Molecular , Femenino , Cardiopatías Congénitas/genética , Heterocigoto , Proteínas de Homeodominio , Humanos , Masculino , Datos de Secuencia Molecular , Homología de Secuencia de Aminoácido , Dedos de Zinc/genética
14.
JAMA ; 278(1): 51-7, 1997 Jul 02.
Artículo en Inglés | MEDLINE | ID: mdl-9207339

RESUMEN

OBJECTIVE: Neurofibromatosis 1 and neurofibromatosis 2 are autosomal dominant genetic disorders in which affected individuals develop both benign and malignant tumors at an increased frequency. Since the original National Institutes of Health Consensus Development Conference in 1987, there has been significant progress toward a more complete understanding of the molecular bases for neurofibromatosis 1 and neurofibromatosis 2. Our objective was to determine the diagnostic criteria for neurofibromatosis 1 and neurofibromatosis 2, recommendations for the care of patients and their families at diagnosis and during routine follow-up, and the role of DNA diagnostic testing in the evaluation of these disorders. DATA SOURCES: Published reports from 1966 through 1996 obtained by MEDLINE search and studies presented at national and international meetings. STUDY SELECTION: All studies were reviewed and analyzed by consensus from multiple authors. DATA EXTRACTION: Peer-reviewed published data were critically evaluated by independent extraction by multiple authors. DATA SYNTHESIS: The main results of the review were qualitative and were reviewed by neurofibromatosis clinical directors worldwide through an Internet Web site. CONCLUSIONS: On the basis of the information presented in this review, we propose a comprehensive approach to the diagnosis and treatment of individuals with neurofibromatosis 1 and neurofibromatosis 2.


Asunto(s)
Neurofibromatosis 1/diagnóstico , Neurofibromatosis 2/diagnóstico , Genes de Neurofibromatosis 1 , Genes de la Neurofibromatosis 2 , Pruebas Genéticas , Humanos , Neurofibromatosis 1/genética , Neurofibromatosis 1/terapia , Neurofibromatosis 2/genética , Neurofibromatosis 2/terapia , Índice de Severidad de la Enfermedad
15.
Prenat Diagn ; 17(5): 443-50, 1997 May.
Artículo en Inglés | MEDLINE | ID: mdl-9178319

RESUMEN

We present a case of maternal uniparental heterodisomy for chromosome 2 (UPD 2) detected after trisomy 2 mosaicism was found on placental biopsy. This case presented prenatally with severe intrauterine growth restriction (IUGR) and oligohydramnios. The diploid newborn had hypospadias and features consistent with oligohydramnios sequence. He died shortly after birth of severe pulmonary hypoplasia. The term placenta had high levels of trisomy 2 in both the trophoblast and the stroma. A comparison of this case with others reported in the literature suggests that the IUGR and oligohydramnios are likely related to placental insufficiency due to the high levels of trisomy 2 present in the trophoblast of the term placenta and the presence of UPD 2 in the diploid placental line.


Asunto(s)
Cromosomas Humanos Par 2/genética , Retardo del Crecimiento Fetal/genética , Hipospadias/genética , Mosaicismo , Oligohidramnios/metabolismo , Placenta/metabolismo , Trisomía , Femenino , Humanos , Masculino
16.
Cell ; 89(5): 773-9, 1997 May 30.
Artículo en Inglés | MEDLINE | ID: mdl-9182765

RESUMEN

Cleidocranial dysplasia (CCD) is an autosomal-dominant condition characterized by hypoplasia/aplasia of clavicles, patent fontanelles, supernumerary teeth, short stature, and other changes in skeletal patterning and growth. In some families, the phenotype segregates with deletions resulting in heterozygous loss of CBFA1, a member of the runt family of transcription factors. In other families, insertion, deletion, and missense mutations lead to translational stop codons in the DNA binding domain or in the C-terminal transactivating region. In-frame expansion of a polyalanine stretch segregates in an affected family with brachydactyly and minor clinical findings of CCD. We conclude that CBFA1 mutations cause CCD and that heterozygous loss of function is sufficient to produce the disorder.


Asunto(s)
Cromosomas Humanos Par 6 , Displasia Cleidocraneal/genética , Proteínas de Neoplasias , Factores de Transcripción/genética , Alelos , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Subunidad alfa 1 del Factor de Unión al Sitio Principal , Eliminación de Gen , Humanos , Ratones , Datos de Secuencia Molecular
17.
Hum Mol Genet ; 6(1): 123-7, 1997 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9002680

RESUMEN

Oculodentodigital syndrome (ODD) is a congenital, autosomal dominant disorder which affects the development of the face, eyes, limbs and dentition. Spastic paraparesis is thought to be an occasional manifestation of the disorder. Type III syndactyly, which occurs as part of ODD, has also been reported to occur as an isolated entity. In the current investigation, a total genome search for the location of the ODD locus was instigated and linkage to polymorphic markers located on chromosome 6q established (pairwise Zmax = 9.37; theta = 0.001). Analysis of a large family with type III syndactyly, but atypical facial features, further suggested that isolated type III syndactyly is also located in this same region of the genome.


Asunto(s)
Anomalías Múltiples/genética , Cromosomas Humanos Par 6 , Sindactilia/genética , Mapeo Cromosómico , Anomalías del Ojo/genética , Cara/anomalías , Femenino , Marcadores Genéticos , Humanos , Deformidades Congénitas de las Extremidades , Masculino , Linaje , Síndrome , Anomalías Dentarias/genética
18.
Teratology ; 56(6): 358-62, 1997 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-9485545

RESUMEN

Female monozygotic (MZ) twins were discordant for congenital structural anomalies: Twin A had a reduction defect of the right forearm; Twin B had a cleft palate. Both infants were small for gestational age. Specific prenatal exposures were identified at different times in the first trimester of pregnancy: crack cocaine, marijuana, disulfiram, heavy ethanol exposure, and cigarettes. The mother's hospitalization in a drug abuse program and incarceration allowed for identification of exposure timing. The cleft palate could have been related to either disulfiram or alcohol exposure; the limb abnormality most likely corresponded to the timing of disulfiram exposure. Discordance of anomalies in these twins may reflect differences in developmental timing, differences in susceptibility to one or more teratogens, or random events occurring within very complex developmental programs, with the thresholds for malformation affected by one or multiple teratogenic compounds.


Asunto(s)
Anomalías Inducidas por Medicamentos , Disuasivos de Alcohol/efectos adversos , Disulfiram/efectos adversos , Efectos Tardíos de la Exposición Prenatal , Gemelos Monocigóticos , Adulto , Consumo de Bebidas Alcohólicas , Fisura del Paladar/inducido químicamente , Femenino , Humanos , Embarazo , Radiografía , Radio (Anatomía)/anomalías , Radio (Anatomía)/diagnóstico por imagen , Radio (Anatomía)/efectos de los fármacos , Fumar , Trastornos Relacionados con Sustancias , Cúbito/anomalías , Cúbito/diagnóstico por imagen , Cúbito/efectos de los fármacos
19.
Neurogenetics ; 1(2): 95-102, 1997 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10732810

RESUMEN

We examined 11 Caucasian pedigrees with autosomal dominant 'uncomplicated' familial spastic paraplegia (SPG) for linkage to the previously identified loci on chromosomes 2p, 14q and 15q. Chromosome 15q was excluded for all families. Five families showed evidence for linkage to chromosome 2p, one to chromosome 14q, and five families remained indeterminate. Homogeneity analysis of combined chromosome 2p and 14q data gave no evidence for a fourth as yet unidentified SPG locus. Recombination events reduced the chromosome 2p minimum candidate region (MCR) to a 3 cM interval between D2S352 and D2S367 and supported the previously reported 7 cM MCR for chromosome 14q. Age of onset (AO) was highly variable, indicating that subtypes of SPG are more appropriately defined on a genetic basis than by AO. Comparison of AO in parent-child pairs was suggestive of anticipation, with a median difference of 9.0 years (p<0.0001).


Asunto(s)
Cromosomas Humanos Par 2/genética , Genes Dominantes , Paraplejía/genética , Adolescente , Adulto , Edad de Inicio , Anciano , Niño , Preescolar , Mapeo Cromosómico , Cromosomas Humanos Par 14/genética , ADN/genética , Salud de la Familia , Femenino , Heterogeneidad Genética , Ligamiento Genético , Genotipo , Humanos , Lactante , Escala de Lod , Masculino , Repeticiones de Microsatélite , Persona de Mediana Edad , Linaje
20.
Pediatr Neurol ; 15(3): 261-4, 1996 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-8916169

RESUMEN

We studied the seizure disorders manifested by three previously reported children with "de novo" terminal deletions of the long arm of chromosome 1 (46,XX,del(1)(q43)) and similar clinical phenotypes. In late infancy, two of these children developed partial seizures characterized by tonic-clonic movements of the ipsilateral face and arm with occasional involvement of the leg. In both children, the seizure frequency decreased with increasing age. Electroencephalograms of these two children demonstrated centrotemporal spike discharges morphologically similar to rolandic spikes. Although these cases present significant similarities to benign rolandic epilepsy, they also express many manifestations not detected in benign rolandic epilepsy that may reflect the extensive deletion of chromosome 1. Based on the seizure semiology and centrotemporal epileptiform discharges, we suggest that the distal portion of the long arm of chromosome 1 is a potential site for a candidate gene for benign rolandic epilepsy.


Asunto(s)
Deleción Cromosómica , Cromosomas Humanos Par 1 , Epilepsia Rolándica/genética , Convulsiones/genética , Factores de Edad , Electroencefalografía , Epilepsia Rolándica/fisiopatología , Femenino , Humanos , Lactante
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA